Skip To Main Content
Yinxian Yang on Muck Rack

Yinxian Yang

As seen in: Nature, Wiley Online Library, Science Magazine, Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinxian

Contact Yinxian, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Bioresponsive microneedle stent provides anastomosis and postoperative adjuvant therapy in preclinical resectable intestinal diseases

|
By xiaofan LI, Ruyi Zhou, Keenan A. Walker, Dong Cen, MingYu Chen, Junjie Nan, Jiahuan You, Qiang Zheng, Yingke Wu, Hao Yu, Yong Sun, Yinxian Yang, Wei Zhou, Jie Lin, Huimin An, Qingxuan Ye, Yuewei Chen, Zehao Zeng, Xuxu Yang, Yong He, Peng Teng, Jinqiang Wang, Jicheng Yu, Yuqi Zhang, Zhen Gu
| Science Magazine Verified
Editor’s summary Abstract Supplementary Materials REFERENCES AND NOTES Information & Authors Metrics & Citations Check Access References Figures Tables Media Share Editor’s summary Resection of diseased bowel requires rejoining of the remaining intestinal segments and postoperative therapy to support a regenerative environment. Here, Zhou et al.
Open in Who Shared Issue with article?

Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy

|
By Yan Xu, Xiaoge Zhang, Xiao Han, Hanwei Huang, Chaoyang Meng, Yinxian Yang, Tao Sheng, En Ren, Jiaqi Shi, Kaixin He, Dong Cen, Peng Zhao, Weijia Fang, Hongjun Li, Yuqi Zhang, Xiujun Cai, Funan Liu, Jicheng Yu, Zhen Gu
| Cell Press Verified
Keywords drug delivery cell therapy mast cells oncolytic adenoviruses cell-drug conjugate cancer immunotherapy Get full text access Log in, subscribe or purchase for full access. References 1. Vargason, A.M. ∙ Anselmo, A.C. ∙ Mitragotri, S. The evolution of commercial drug delivery technologies Nat. Biomed. Eng. 2021; 5:951-967 2. Lim, W.A. The emerging era of cell engineering: Harnessing the modularity of cells to program complex biological function Science. 2022; 378:848-852 3. Chen, Z. ∙ Hu, Q. ∙ Gu, Z.
Open in Who Shared Issue with article?

Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune response - Nature Cancer

|
By Jinpeng Han, Shenqiang Wang, Yinxian Yang, Ruikang Tang, Zhaoming Liu
| Nature Verified
Abstract Long-acting controlled drug release formulations are highly desired for potentiating efficacy and reducing administration frequency. Here we present a kinetically controllable long-term interleukin-2 (IL-2) release platform by the fusion and boundary elimination of calcium carbonate and calcium phosphate amorphous phases.
Open in Who Shared Issue with article?
See all 9 articles